These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

824 related items for PubMed ID: 15823282

  • 1. Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statins.
    Geiss HC, Otto C, Hund-Wissner E, Parhofer KG.
    Atherosclerosis; 2005 May; 180(1):107-12. PubMed ID: 15823282
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.
    McCormack T, Harvey P, Gaunt R, Allgar V, Chipperfield R, Robinson P, IN-PRACTICE study.
    Int J Clin Pract; 2010 Jul; 64(8):1052-61. PubMed ID: 20487050
    [Abstract] [Full Text] [Related]

  • 5. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
    Ambegaonkar BM, Tipping D, Polis AB, Tomassini JE, Tershakovec AM.
    Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
    [Abstract] [Full Text] [Related]

  • 6. Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients.
    Averna M, Zaninelli A, Le Grazie C, Gensini GF.
    J Clin Lipidol; 2010 Dec; 4(4):272-8. PubMed ID: 21122660
    [Abstract] [Full Text] [Related]

  • 7. Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease.
    Farnier M, Volpe M, Massaad R, Davies MJ, Allen C.
    Int J Cardiol; 2005 Jul 10; 102(2):327-32. PubMed ID: 15982505
    [Abstract] [Full Text] [Related]

  • 8. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.
    Ballantyne CM, Houri J, Notarbartolo A, Melani L, Lipka LJ, Suresh R, Sun S, LeBeaut AP, Sager PT, Veltri EP, Ezetimibe Study Group.
    Circulation; 2003 May 20; 107(19):2409-15. PubMed ID: 12719279
    [Abstract] [Full Text] [Related]

  • 9. Begin with the real-world patients of non-goal-achieved hypercholesterolemia in taiwan through the ezetimibe/simvastatin tablet - The BRAVO Study.
    Huang JC, Lee TY, Liou MJ, Lin CM, Pei D, Chen ZC, Liu RT, Kwok CF.
    Curr Med Res Opin; 2011 Aug 20; 27(8):1645-51. PubMed ID: 21699369
    [Abstract] [Full Text] [Related]

  • 10. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG, Ballantyne CM, Hsueh W, Rosen J, Lin J, Shah A, Lowe RS, Hanson ME, Tershakovec AM.
    J Clin Lipidol; 2011 Aug 20; 5(6):474-82. PubMed ID: 22108151
    [Abstract] [Full Text] [Related]

  • 11. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E, Ezetimibe Study Group.
    Am Heart J; 2004 Sep 20; 148(3):447-55. PubMed ID: 15389231
    [Abstract] [Full Text] [Related]

  • 12. Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.
    Robinson JG, Nedergaard BS, Rogers WJ, Fialkow J, Neutel JM, Ramstad D, Somaratne R, Legg JC, Nelson P, Scott R, Wasserman SM, Weiss R, LAPLACE-2 Investigators.
    JAMA; 2014 May 14; 311(18):1870-82. PubMed ID: 24825642
    [Abstract] [Full Text] [Related]

  • 13. Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.
    Simons L, Tonkon M, Masana L, Maccubbin D, Shah A, Lee M, Gumbiner B.
    Curr Med Res Opin; 2004 Sep 14; 20(9):1437-45. PubMed ID: 15383192
    [Abstract] [Full Text] [Related]

  • 14. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
    Pearson TA, Denke MA, McBride PE, Battisti WP, Brady WE, Palmisano J.
    Mayo Clin Proc; 2005 May 14; 80(5):587-95. PubMed ID: 15887425
    [Abstract] [Full Text] [Related]

  • 15. Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia.
    Tomassini JE, Mazzone T, Goldberg RB, Guyton JR, Weinstock RS, Polis A, Jensen E, Tershakovec AM.
    Diabetes Obes Metab; 2009 Sep 14; 11(9):855-64. PubMed ID: 19508464
    [Abstract] [Full Text] [Related]

  • 16. Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease.
    Barrios V, Amabile N, Paganelli F, Chen JW, Allen C, Johnson-Levonas AO, Massaad R, Vandormael K.
    Int J Clin Pract; 2005 Dec 14; 59(12):1377-86. PubMed ID: 16351668
    [Abstract] [Full Text] [Related]

  • 17. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.
    Yoon HS, Kim SH, Kim JK, Ko SH, Ko JE, Park SJ, Park MG, Lee JH, Hyon MS.
    Ann Pharmacother; 2011 Jul 14; 45(7-8):841-9. PubMed ID: 21693699
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).
    Foody JM, Brown WV, Zieve F, Adewale AJ, Flaim D, Lowe RS, Jones-Burton C, Tershakovec AM.
    Am J Cardiol; 2010 Nov 01; 106(9):1255-63. PubMed ID: 21029821
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW, Liem AH, Dunselman PH, Dallinga-Thie GM, Zwinderman AH, Jukema JW.
    Curr Med Res Opin; 2008 Mar 01; 24(3):685-94. PubMed ID: 18226326
    [Abstract] [Full Text] [Related]

  • 20. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM.
    Curr Med Res Opin; 2006 Oct 01; 22(10):2041-53. PubMed ID: 17022864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.